Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Saverno, KR"'
Autor:
Boytsov, NN, Bhattacharya, R, Saverno, KR, Dixon, L, Abbott, PL, Zhang, X, Larmore, CJ, Datar, M, Gaich, CL, Nair, R
Publikováno v:
In Value in Health May 2018 21 Supplement 1:S201-S202
Publikováno v:
Research in Social & Administrative Pharmacy; Dec2011, Vol. 7 Issue 4, p359-368, 10p
Autor:
Saverno KR (AUTHOR), Hines LE (AUTHOR), Warholak TL (AUTHOR), Grizzle AJ (AUTHOR), Babits L (AUTHOR), Clark C (AUTHOR), Taylor AM (AUTHOR), Malone DC (AUTHOR), Saverno, Kim R1 (AUTHOR), Hines, Lisa E (AUTHOR), Warholak, Terri L (AUTHOR), Grizzle, Amy J (AUTHOR), Babits, Lauren (AUTHOR), Clark, Courtney (AUTHOR), Taylor, Ann M (AUTHOR), Malone, Daniel C (AUTHOR)
Publikováno v:
Journal of the American Medical Informatics Association. Jan2011, Vol. 18 Issue 1, p32-37. 6p.
Publikováno v:
American Health & Drug Benefits; Nov2009, Vol. 2 Issue 7, p309-315, 7p
Publikováno v:
Journal of the American Pharmacists Association: JAPhA; Sep/Oct2011, Vol. 51 Issue 5, p570-572, 3p
Autor:
Smyth EN; Eli Lilly and Company, Indianapolis, IN, USA. nash_smyth_emily@lilly.com., Beyrer J; Eli Lilly and Company, Indianapolis, IN, USA., Saverno KR; Eli Lilly and Company, Indianapolis, IN, USA., Hadden E; DeLisle & Associates, Ltd, Indianapolis, IN, USA., Abedtash H; Eli Lilly and Company, Indianapolis, IN, USA., DeLuca A; Eli Lilly and Company, Indianapolis, IN, USA., Lawrence GW; Eli Lilly and Company, Indianapolis, IN, USA., Rybowski S; Eli Lilly and Company, Indianapolis, IN, USA.
Publikováno v:
Drugs - real world outcomes [Drugs Real World Outcomes] 2022 Dec; Vol. 9 (4), pp. 681-693. Date of Electronic Publication: 2022 Sep 12.
Autor:
Ivanova JI; Analysis Group, Inc., 10 Rockefeller Plaza, 15th Floor, New York, NY, 10020, USA. jasmina.ivanova@analysisgroup.com., Saverno KR; Vector Oncology, Memphis, TN, USA., Sung J; Sanofi US, Bridgewater, NJ, USA., Duh MS; Analysis Group, Inc., Boston, MA, USA., Zhao C; Analysis Group, Inc., 10 Rockefeller Plaza, 15th Floor, New York, NY, 10020, USA., Cai S; Analysis Group, Inc., 10 Rockefeller Plaza, 15th Floor, New York, NY, 10020, USA., Vekeman F; Analysis Group, Inc., Montreal, QC, Canada., Peevyhouse A; Vector Oncology, Memphis, TN, USA., Dhawan R; Sanofi US, Bridgewater, NJ, USA., Fuchs CS; Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
Publikováno v:
Medical oncology (Northwood, London, England) [Med Oncol] 2017 Nov 04; Vol. 34 (12), pp. 193. Date of Electronic Publication: 2017 Nov 04.
Autor:
Racsa PN; 1 Comprehensive Health Insights, Humana, Louisville, Kentucky., Meah Y; 2 Humana, Louisville, Kentucky., Ellis JJ; 1 Comprehensive Health Insights, Humana, Louisville, Kentucky., Saverno KR; 1 Comprehensive Health Insights, Humana, Louisville, Kentucky.
Publikováno v:
Journal of managed care & specialty pharmacy [J Manag Care Spec Pharm] 2017 Mar; Vol. 23 (3), pp. 291-298.
Autor:
Buck PO; GSK, Philadelphia, PA. Electronic address: philip.o.buck@gsk.com., Saverno KR; Vector Oncology Solutions, Memphis, TN., Miller PJ; Vector Oncology Solutions, Memphis, TN., Arondekar B; GSK, Philadelphia, PA., Walker MS; Vector Oncology Solutions, Memphis, TN.
Publikováno v:
Clinical lung cancer [Clin Lung Cancer] 2015 Nov; Vol. 16 (6), pp. 486-95. Date of Electronic Publication: 2014 Dec 31.
Autor:
Saverno KR; Department of Public Health and Health Technology Assessment, Institute of Public Health, Medical Decision Making and Health Technology Assessment, UMIT, University for Health Sciences, Medical Informatics, and Technology, Hall in Tirol, Austria., Rochau U, Stenehjem DD, Morley K, Siebert U, Brixner DI
Publikováno v:
Journal of managed care pharmacy : JMCP [J Manag Care Pharm] 2012 Jul-Aug; Vol. 18 (6), pp. 457-63.